Compare Solstice Advanced Materials Inc. Common Stock (SOLS) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Solstice Advanced Materials Inc. Common Stock vs DENTSPLY SIRONA Inc — how do they compare? Solstice Advanced Materials Inc. Common Stock trades at $58.75 (market cap $9.55B), while DENTSPLY SIRONA Inc trades at $8.5 (market cap $1.68B). The key difference: Solstice Advanced Materials Inc. Common Stock is far larger — about 5.7× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays the higher dividend (5.04%). Which is the better fit depends on your goals — on Pluang, investors hold Solstice Advanced Materials Inc. Common Stock for 0 Days and DENTSPLY SIRONA Inc for 72 Days on average.
| SOLS | XRAY | |
|---|---|---|
Market Cap | $9.55B | $1.68B |
Volume | 2,661,277 | 3,968,929 |
Sector | Basic Materials | Health |
52-Week High | $88.60 | $14.68 |
52-Week Low | $41.43 | $8.44 |
Typical Hold Time | 0 Days | 72 Days |
Enterprise Value | $11.23B | $3.76B |
Dividend Yield | 0.5% | 5.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Solstice Advanced Materials (SOLS) trades at $60.91, up 0.33% with neutral technical signals. The company shows strong profitability with 30.64% gross margins and 14.95% ROE, though Q4 2025 earnings missed expectations. Recent developments include a $49M R&D expansion and termination of the Element Solutions merger, with the board authorizing a $500M share repurchase program. Analyst consensus is bullish with 80% buy ratings and a $80.22 price target representing 32% upside potential.
SOLS presents a compelling growth story with consistent earnings beats and institutional accumulation, though elevated P/E of 46.07 warrants caution. Key risks include execution challenges post-merger termination and margin pressure as profit margins declined from 6.09% to 5.12% year-over-year. The stock offers substantial upside if management delivers on growth initiatives while maintaining current profitability levels.
DENTSPLY SIRONA (XRAY) trades at $8.51, near its 52-week low, with a bearish technical outlook. The company reported a net loss of $598 million in 2025, with negative profit margins and declining revenue. Recent Q2 2026 earnings beat estimates, but sales fell 4.1% year-over-year. Analyst consensus is mixed, with a $12.50 price target but more hold than buy ratings.
The stock faces significant headwinds from weak profitability and competitive pressures, though cost-cutting and digital dentistry investments offer long-term potential. High debt levels and ongoing margin pressure present substantial risks. Upside depends on successful execution of the turnaround plan and stabilization of core dental markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Solstice Advanced Materials Inc. Common Stock
Solstice Advanced Materials Inc. is a specialty materials company spun off from Honeywell in 2025, producing low-global-warming-potential refrigerants, blowing agents, and industrial solvents through its Refrigerants and Applied Solutions segment. Its Electronic and Specialty Materials segment supplies semiconductor materials, high-strength fibers, and healthcare-packaging films.
Read more on SOLS →About DENTSPLY SIRONA Inc
Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →
